Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives
Abstract
:1. Introduction
2. Procedural Steps
3. Fluoroscopy
4. TEE
5. Intracardiac Echography (ICE)
6. Future Perspectives
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Correale, M.; Paolillo, S.; Mercurio, V.; Limongelli, G.; Barillà, F.; Ruocco, G.; Palazzuoli, A.; Scrutinio, D.; Lagioia, R.; Lombardi, C.; et al. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure. Eur. J. Intern. Med. 2020, 71, 23–31. [Google Scholar] [CrossRef] [PubMed]
- Benjamin, E.J.; Muntner, P.; Alonso, A.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Chang, A.R.; Cheng, S.; Das, S.R.; et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2019 update: A report from the American Heart Association. Circulation 2019, 139, e56–e58. [Google Scholar] [CrossRef] [PubMed]
- Hindricks, G.; Potpara, T.; Dagres, N.; Arbelo, E.; Bax, J.J.; Blomström-Lundqvist, C.; Boriani, G.; Castella, M.; Dan, G.A.; Dilaveris, P.E.; et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021, 42, 373–498. [Google Scholar]
- Romiti, G.F.; Pastori, D.; Rivera-Caravaca, J.M.; Ding, W.Y.; Gue, Y.X.; Menichelli, D.; Gumprecht, J.; Kozieł, M.; Yang, P.S.; Guo, Y.; et al. Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. Thromb. Haemost. 2022, 122, 406–414. [Google Scholar] [CrossRef] [PubMed]
- Pisters, R.; Lane, D.A.; Marin, F.; Camm, A.J.; Lip, G.Y. Stroke and thromboembolism in atrial fibrillation. Circ. J. 2012, 76, 2289–2304. [Google Scholar] [CrossRef] [PubMed]
- Marini, C.; De Santis, F.; Sacco, S.; Russo, T.; Olivieri, L.; Totaro, R.; Carolei, A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke 2005, 36, 1115–1119. [Google Scholar] [CrossRef]
- Patanè, S.; Marte, F.; Dattilo, G.; Sturiale, M. Changing axis deviation during atrial fibrillation. Int. J. Cardiol. 2012, 154, e1–e3. [Google Scholar] [CrossRef]
- Tulino, D.; Imbalzano, E.; Casale, M.; D’Angelo, M.; Coglitore, S.; Di Bella, G.; Dattilo, G. Treatment failure of low molecular weight heparin in diabetic patient. Int. J. Cardiol. 2013, 168, e63–e64. [Google Scholar] [CrossRef]
- Allan, V.; Honarbakhsh, S.; Casas, J.P.; Wallace, J.; Hunter, R.; Schilling, R.; Perel, P.; Morley, K.; Banerjee, A.; Hemingway, H. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb. Haemost. 2017, 117, 837–850. [Google Scholar] [CrossRef]
- Lip, G.Y.; Nieuwlaat, R.; Pisters, R.; Lane, D.A.; Crijns, H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Chest 2010, 137, 263–272. [Google Scholar] [CrossRef]
- Paolillo, S.; Ruocco, G.; Filardi, P.P.; Palazzuoli, A.; Tocchetti, C.G.; Nodari, S.; Lombardi, C.; Metra, M.; Correale, M. “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology. Direct oral anticoagulants across the heart failure spectrum: The precision medicine era. Heart Fail. Rev. 2022, 27, 135–145. [Google Scholar] [CrossRef]
- Székely, O.; Borgi, M.; Lip, G.Y.H. Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation. Expert. Opin. Emerg. Drugs 2019, 24, 55–61. [Google Scholar] [CrossRef] [PubMed]
- Ozaki, A.F.; Choi, A.S.; Le, Q.T.; Ko, D.T.; Han, J.K.; Park, S.S.; Jackevicius, C.A. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. Circ. Cardiovasc. Qual. Outcomes 2020, 13, e005969. [Google Scholar] [CrossRef] [PubMed]
- Marzec, L.N.; Wang, J.; Shah, N.D.; Chan, P.S.; Ting, H.H.; Gosch, K.L.; Hsu, J.C.; Maddox, T.M. Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation. J. Am. Coll. Cardiol. US 2017, 69, 2475–2484. [Google Scholar] [CrossRef] [PubMed]
- Dattilo, G.; Lamari, A.; Di Bella, G.; Scarano, M.; De Luca, E.; Mutone, D.; Busacca, P.; Coglitore, S. Treatment failure of low molecular weight heparin bridging therapy. Int. J. Cardiol. 2013, 167, e106–e107. [Google Scholar] [CrossRef] [PubMed]
- Patanè, S.; Marte, F.; Risica, G.; Giannetto, L.; La Rosa, F.C.; La Rocca, R.; Dattilo, G.; Sturiale, M. Treatment failure of low molecular weight heparin bridging therapy before a cardiac surgery intervention in a patient with atrial fibrillation. Int. J. Cardiol. 2009, 137, e59–e60. [Google Scholar] [CrossRef]
- Watson, T.; Shantsila, E.; Lip, G.Y. Mechanisms of thrombogen-esis in atrial fibrillation: Virchow’s triad revisited. Lancet 2009, 373, 155–166. [Google Scholar] [CrossRef]
- Dattilo, G.; Falanga, G.; Casale, M.; D’Angelo, M.; Quattrocchi, S.; Lamari, A. Oral Anticoagulants: Old and New Therapy. In Advances in Medicine and Biology; Berhardt, L.V., Ed.; Nova Science Publishers, Inc.: New York, NY, USA, 2015; Volume 83, pp. 13–70. [Google Scholar]
- Mahajan, R.; Brooks, A.G.; Sullivan, T.; Lim, H.S.; Alasady, M.; Abed, H.S.; Ganesan, A.N.; Nayyar, S.; Lau, D.H.; Roberts-Thomson, K.C.; et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: Implications for left atrial appendage closure. Heart 2012, 98, 1120–1126. [Google Scholar] [CrossRef]
- Blackshear, J.L.; Odell, J.A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 1996, 61, 755–759. [Google Scholar] [CrossRef]
- Fountain, R.B.; Holmes, D.R.; Chandrasekaran, K.; Packer, D.; Asirvatham, S.; Van Tassel, R.; Turi, Z. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am. Heart J. 2006, 151, 956–961. [Google Scholar] [CrossRef]
- Belgaid, D.R.; Khan, Z.; Zaidi, M.; Hobbs, A. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. Int. J. Cardiol. 2016, 219, 177–179. [Google Scholar] [CrossRef] [PubMed]
- Reddy, V.Y.; Doshi, S.K.; Kar, S.; Gibson, D.N.; Price, M.J.; Huber, K.; Horton, R.P.; Buchbinder, M.; Neuzil, P.; Gordon, N.T.; et al. 5-Year Outcomes after Left Atrial Appendage Closure. From the PREVAIL and PROTECT AF Trials. J. Am. Coll. Cardiol. 2017, 70, 2964–2975. [Google Scholar] [CrossRef] [PubMed]
- Reddy, V.Y.; Gibson, D.N.; Kar, S.; O’Neill, W.; Doshi, S.K.; Horton, R.P.; Buchbinder, M.; Gordon, N.T.; Holmes, D.R. Post-Approval U.S. Experience with Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. J. Am. Coll. Cardiol. 2017, 69, 253–261. [Google Scholar] [CrossRef]
- Alkhouli, M.; Ellis, C.; Daniels, M.; Coylewright, M.; Nielsen-Kudsk, J.E.; Holmes, D.R. Left Atrial Appendage Occlusion. JACC Adv. 2022, 1, 100136. [Google Scholar] [CrossRef]
- Osmancik, P.; Tousek, P.; Herman, D.; Neuzil, P.; Hala, P.; Stasek, J.; Haman, L.; Kala, P.; Poloczek, M.; Branny, M.; et al. Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study). Am. Heart J. 2017, 183, 108–114. [Google Scholar] [CrossRef]
- Cruz-González, I.; Korsholm, K.; Trejo-Velasco, B.; Thambo, J.B.; Mazzone, P.; Rioufol, G.; Grygier, M.; Möbius-Winkler, S.; Betts, T.; Meincke, F.; et al. Procedural and Short-Term Results with the New Watchman FLX Left Atrial Appendage Occlusion Device. JACC Cardiovasc. Interv. 2020, 13, 2732–2741. [Google Scholar] [CrossRef]
- Vizzari, G.; Grasso, C.; Sardone, A.; Mazzone, P.; Laterra, G.; Frazzetto, M.; Sacchetta, G.; Micari, A.; Tamburino, C.; Contarini, M. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry. Catheter. Cardiovasc. Interv. 2022, 100, 154–160. [Google Scholar] [CrossRef]
- Saad, M.; Risha, O.; Sano, M.; Fink, T.; Heeger, C.H.; Vogler, J.; Sciacca, V.; Eitel, C.; Stiermaier, T.; Joost, A. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience. Int. J. Cardiol. Heart. Vasc. 2021, 37, 100893. [Google Scholar] [CrossRef]
- Holmes, D.R., Jr.; Reddy, V.Y.; Gordon, N.T.; Delurgio, D.; Doshi, S.K.; Desai, A.J.; Stone, J.E., Jr.; Kar, S. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. J. Am. Coll. Cardiol. 2019, 74, 2878–2889. [Google Scholar] [CrossRef]
- Osmancik, P.; Herman, D.; Neuzil, P.; Hala, P.; Taborsky, M.; Kala, P.; Poloczek, M.; Stasek, J.; Haman, L.; Branny, M.; et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients with Atrial Fibrillation. J. Am. Coll. Cardiol. 2020, 75, 3122–3135. [Google Scholar] [CrossRef]
- Korsholm, K.; Damgaard, D.; Valentin, J.B.; Packer, E.J.S.; Odenstedt, J.; Sinisalo, J.; Putaala, J.; Næss, H.; Al-Jazi, M.A.; Karlsson, J.E. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: Rationale and design of the multicenter randomized occlusion-AF trial. Heart J. 2022, 243, 28–38. [Google Scholar] [CrossRef] [PubMed]
- Huijboom, M.; Maarse, M.; Aarnink, E.; van Dijk, V.; Swaans, M.; van der Heijden, J.; IJsselmuiden, S.; Folkeringa, R.; Blaauw, Y.; Elvan, A. COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy. Am. Heart J. 2022, 250, 45–56. [Google Scholar] [PubMed]
- Wintgens, L.I.S.; Maarse, M.; Swaans, M.J.; Rensing, B.J.W.M.; Van Dijk, V.F.; Boersma, L.V.A. Rensing The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: Current status and future perspectives. Expert. Rev. Med. Devices 2020, 17, 615–626. [Google Scholar] [CrossRef]
- Glikson, M.; Wolff, R.; Hindricks, G.; Mandrola, J.; Camm, A.J.; Lip, G.Y.H.; Fauchier, L.; Betts, T.R.; Lewalter, T.; Saw, J. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion—An update. EuroIntervention 2020, 15, 1133–1180. [Google Scholar] [CrossRef]
- Galea, R.; Räber, L.; Fuerholz, M.; Häner, J.D.; Siontis, G.C.M.; Brugger, N.; Moschovitis, A.; Heg, D.; Fischer, U.; Meier, B. Impact of Echocardiographic Guidance on Safety and Efficacy of Left Atrial Appendage Closure. JACC Cardiovasc. Interv. 2021, 14, 1815–1826. [Google Scholar] [CrossRef]
- Yuniadi, Y.; Hanafy, D.A.; Raharjo, S.B.; Yugo, D. Left atrial appendage closure device implantation guided with fluoroscopy only: Long-term results. J. Arrhythm. 2019, 35, 262–266. [Google Scholar] [CrossRef] [PubMed]
- Saw, J.; Fahmy, P.; Spencer, R.; Prakash, R.; McLaughlin, P.; Nicolaou, S.; Tsang, M. Comparing measurements of CT angiography, TEE, and fluoroscopy of the left atrial appendage for per-cutaneous closure. J. Cardiovasc. Electrophysiol. 2016, 27, 414–422. [Google Scholar] [CrossRef]
- Zamorano, J.; Gonçalves, A.; Lancellotti, P.; Andersen, K.A.; González-Gómez, A.; Monaghan, M.; Brochet, E.; Wunderlich, N.; Gafoor, S.; Gillam, L.D.; et al. The use of imaging in new transcatheter interventions: An EACVI review paper. Eur. Heart J. Cardiovasc. Imaging 2016, 17, 835. [Google Scholar] [CrossRef]
- Alkhouli, M.; Rihal, C.S.; Holmes, D.R., Jr. Transseptal Techniques for Emerging Structural Heart Interventions. JACC Cardiovasc. Interv. 2016, 9, 2465–2480. [Google Scholar] [CrossRef]
- Zito, C.; Dattilo, G.; Oreto, G.; Di Bella, G.; Lamari, A.; Iudicello, R.; Trio, O.; Caracciolo, G.; Coglitore, S.; Arrigo, F. Patent foramen ovale: Comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography 2009, 26, 495–503. [Google Scholar] [CrossRef]
- de Gregorio, C.; Dattilo, G.; Casale, M.; Terrizzi, A.; Donato, R.; Di Bella, G. Left Atrial Morphology, Size and Function in Patients with Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy—Comparative Strain Imaging Study. Circ. J. 2016, 80, 1830–1837. [Google Scholar] [CrossRef]
- Alkhouli, M.; Chaker, Z.; Alqahtani, F.; Raslan, S.; Raybuck, B. Outcomes of Routine Intracardiac Echocardiography to Guide Left Atrial Appendage Occlusion. JACC Clin. Electrophysiol. 2020, 6, 393–400. [Google Scholar] [CrossRef] [PubMed]
- Alkhouli, M.; Hijazi, Z.M.; Holmes, D.R., Jr.; Rihal, C.S.; Wiegers, S.E. Intracardiac Echocardiography in Structural Heart Disease Interventions. JACC Cardiovasc. Interv. 2018, 11, 2133–2147. [Google Scholar] [CrossRef] [PubMed]
- Korsholm, K.; Jensen, J.M.; Nielsen-Kudsk, J.E. Intracardiac echocardiography from the left atrium for procedural guidance of transcatheter left atrial appendage occlusion. J. Am. Coll. Cardiol. Intv. 2017, 10, 2198–2206. [Google Scholar] [CrossRef]
- Frangieh, A.H.; Alibegovic, J.; Templin, C.; Gaemperli, O.; Obeid, S.; Manka, R.; Holy, E.W.; Maier, W.; Lüscher, T.F.; Binder, R.K. Intracardiac versus transesophageal echocardiog-raphy for left atrial appendage occlusion with watchman. Catheter. Cardiovasc. Interv. 2017, 90, 331–338. [Google Scholar] [CrossRef]
- Masson, J.B.; Kouz, R.; Riahi, M.; Nguyen Thanh, H.K.; Potvin, J.; Naim, C.; Salem, R.; Raymond, J.M. Transcatheter left atrial appendage closure using intracardiac echocardiographic guidance from the left atrium. Can. J. Cardiol. 2015, 31, 1497.e7–1497.e14. [Google Scholar] [CrossRef] [PubMed]
- Velagapudi, P.; Turagam, M.K.; Kolte, D.; Khera, S.; Gupta, T.; Garg, J.; Abbott, J.D.; George, I.; Khalique, O.; Vahl, T.; et al. Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta-analysis. J. Cardiovasc. Electrophysiol. 2019, 30, 461–467. [Google Scholar] [CrossRef]
- Nielsen-Kudsk, J.E.; Berti, S.; Caprioglio, F.; Ronco, F.; Arzamendi, D.; Betts, T.; Tondo, C.; Christen, T.; Allocco, D.J. Intracardiac Echocardiography to Guide Watchman FLX Implantation. J. Am. Coll. Cardiol. Intv. 2023, 16, 643–651. [Google Scholar] [CrossRef] [PubMed]
- Alkhouli, M.; Simard, T.; El Shaer, A.; Bird, J.; Nkomo, V.T.; Freidman, P.A.; Thaden, J.; Padang, R. First Experience with a Novel Live 3D ICE Catheter to Guide Transcatheter Structural Heart Interventions. JACC Cardiovasc. Imaging 2022, 15, 1502–1509. [Google Scholar] [CrossRef]
- Mitchell-Heggs, L.; Lim, P.; Bensaid, A.; Kloeckner, M.; Monin, J.L.; Castanie, J.B.; Hosseini, H.; Nahum, J.; Teiger, E.; Dubois-Randé, J.L.; et al. Usefulness of trans-oesophageal echocardiography using intracardiac echography probe in guiding patent foramen ovale percutaneous closure. Eur. J. Echocardiogr. 2010, 11, 394–400. [Google Scholar] [CrossRef]
- Barker, P.C. Intracardiac echocardiography in congenital heart disease. J. Cardiovasc. Transl. Res. 2009, 2, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Bruce, C.J.; O’Leary, P.; Hagler, D.J.; Seward, J.B.; Cabalka, A.K. Miniaturized transesophageal echocardiography in newborn infants. J. Am. Soc. Echocardiogr. 2002, 15, 791–797. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Laterra, G.; Dattilo, G.; Correale, M.; Brunetti, N.D.; Artale, C.; Sacchetta, G.; Pistelli, L.; Borgi, M.; Campanella, F.; Cocuzza, F.; et al. Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives. J. Clin. Med. 2023, 12, 3756. https://doi.org/10.3390/jcm12113756
Laterra G, Dattilo G, Correale M, Brunetti ND, Artale C, Sacchetta G, Pistelli L, Borgi M, Campanella F, Cocuzza F, et al. Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives. Journal of Clinical Medicine. 2023; 12(11):3756. https://doi.org/10.3390/jcm12113756
Chicago/Turabian StyleLaterra, Giulia, Giuseppe Dattilo, Michele Correale, Natale Daniele Brunetti, Claudia Artale, Giorgio Sacchetta, Lorenzo Pistelli, Marco Borgi, Francesca Campanella, Federica Cocuzza, and et al. 2023. "Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives" Journal of Clinical Medicine 12, no. 11: 3756. https://doi.org/10.3390/jcm12113756
APA StyleLaterra, G., Dattilo, G., Correale, M., Brunetti, N. D., Artale, C., Sacchetta, G., Pistelli, L., Borgi, M., Campanella, F., Cocuzza, F., Lo Nigro, M. C., & Contarini, M. (2023). Imaging Modality to Guide Left Atrial Appendage Closure: Current Status and Future Perspectives. Journal of Clinical Medicine, 12(11), 3756. https://doi.org/10.3390/jcm12113756